InCube Labs L.L.C. 13D and 13G filings for Rani Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-08-23 4:35 pm Purchase |
2021-08-03 | 13D | Rani Therapeutics Holdings, Inc. RANI |
InCube Labs L.L.C. | 22,411,124 44.300% |
22,411,124 (New Position) |
Filing |